Imunon Inc (IMNN)
1.38
-0.13
(-8.61%)
USD |
NASDAQ |
May 10, 16:00
1.41
+0.03
(+2.17%)
After-Hours: 20:00
Imunon SG&A Expense (Quarterly): 2.415M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.415M |
September 30, 2023 | 1.923M |
June 30, 2023 | 2.340M |
March 31, 2023 | 3.065M |
December 31, 2022 | 4.048M |
September 30, 2022 | 3.891M |
June 30, 2022 | 2.877M |
March 31, 2022 | 2.872M |
December 31, 2021 | 2.630M |
September 30, 2021 | 2.718M |
June 30, 2021 | 2.603M |
March 31, 2021 | 2.937M |
December 31, 2020 | 2.109M |
September 30, 2020 | 1.793M |
June 30, 2020 | 1.901M |
March 31, 2020 | 1.839M |
December 31, 2019 | 1.807M |
September 30, 2019 | 1.838M |
June 30, 2019 | 2.137M |
March 31, 2019 | 2.218M |
December 31, 2018 | 2.532M |
September 30, 2018 | 1.960M |
June 30, 2018 | 3.543M |
March 31, 2018 | 1.665M |
December 31, 2017 | 1.598M |
Date | Value |
---|---|
September 30, 2017 | 1.174M |
June 30, 2017 | 1.649M |
March 31, 2017 | 1.468M |
December 31, 2016 | 1.638M |
September 30, 2016 | 1.496M |
June 30, 2016 | 1.529M |
March 31, 2016 | 1.862M |
December 31, 2015 | 1.370M |
September 30, 2015 | 1.484M |
June 30, 2015 | 1.802M |
March 31, 2015 | 2.032M |
December 31, 2014 | 2.077M |
September 30, 2014 | 2.044M |
June 30, 2014 | 2.305M |
March 31, 2014 | 2.434M |
December 31, 2013 | 1.518M |
September 30, 2013 | 1.390M |
June 30, 2013 | 1.951M |
March 31, 2013 | 1.689M |
December 31, 2012 | 1.786M |
September 30, 2012 | 1.420M |
June 30, 2012 | 1.595M |
March 31, 2012 | 1.570M |
December 31, 2011 | 1.249M |
September 30, 2011 | 1.409M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.793M
Minimum
Sep 2020
4.048M
Maximum
Dec 2022
2.513M
Average
2.415M
Median
Dec 2023
SG&A Expense (Quarterly) Benchmarks
Avalo Therapeutics Inc | 2.676M |
iBio Inc | 2.961M |
Ocugen Inc | 5.155M |
Petros Pharmaceuticals Inc | 2.879M |
Moderna Inc | 274.00M |